Blog

October 14, 2018

ASHG Is Upon Us!

We hope to see you at ASHG! This year’s annual ASHG meeting, the largest human genetics conference, comes at the perfect time for us following recent activities and announcements, now culminating in this upcoming conference: We partnered with New England Biolabs to deliver an End-to-End Data Analysis solution for NEBNext...
Read more
July 18, 2018

England Reaches a Genomics Milestone with Routine DNA testing Across the Country

A huge leap forward has occurred in precision medicine: NHS cancer and other disease patients in England will be offered routine genomic testing starting as early as October of this year. This is the first health service of this kind, being offered in the world and is being built on...
Read more
June 15, 2018

BlueBee Achieves ISO 13485 Medical Device Quality Standard Certification

Rijswijk, The Netherlands June 15, 2018 – BlueBee, a global bioinformatics solutions provider, has announced today that it has been awarded the ISO 13485:2016 certification. ISO 13485 is an internationally recognized medical device quality management systems standard, which was awarded to BlueBee for its design and development of software solutions and data...
Read more
June 12, 2018

Lexogen and BlueBee Collaborate to Streamline QuantSeq-UMI Sequencing Data Analysis Pipeline

VIENNA, AUSTRIA, AND RIJSWIJK, THE NETHERLANDS, June 12, 2018 – Lexogen, a transcriptomics and next-generation sequencing company and BlueBee, a global bioinformatics platform, have announced today the implementation of QuantSeq Unique Molecular Identifiers (UMI) data analysis pipeline on the BlueBee genomics analysis platform. This collaboration offers QuantSeq users utilizing UMIs...
Read more
May 16, 2018

BlueBee introduces BLUEBASE, a streamlined solution transforming data into actionable knowledge for clinical and translational genomics research

RIJSWIJK, THE NETHERLANDS, May 16, 2018 — BlueBee Corporation announced today the release of BLUEBASE, a complete data management solution designed to transform next-generation sequencing (NGS) and metadata into actionable genomic knowledge with efficiency and clinical-grade security. BLUEBASE runs on the BlueBee core data analysis platform and provides post-sequencing intelligent...
Read more
March 15, 2018

Data Analysis, Aggregation And Management Have an Essential Role to Play in Gaining Insights and Wisdom From Genomic Data

Precision Medicine Forum Editor Mark Glover spoke to the BlueBee’s CEO Hans Cobben (pictured) about enabling and facilitating the potential of precision medicine through data analysis. BlueBee offers an advanced global bio-informatics platform to analyse, share and store genomics data. It supports users in clinical diagnostics, pharma and research with advanced analytics...
Read more
February 8, 2018

New England Biolabs and BlueBee Partner to Deliver an End-To-End Data Analysis Solution for NEBNext Direct Target Enrichment

RIJSWIJK, The Netherlands & Ipswich, Massachusetts, USA — February 8, 2018 – BlueBee, a company driving global genomic data-driven medicine, and New England Biolabs, Inc. (NEB®) have partnered to provide a secure and convenient data processing solution for NEB’s NEBNext Direct target enrichment technology. Through this partnership, BlueBee enables NEB’s...
Read more
December 19, 2017

Agendia and BlueBee Partner to Bring New NGS-Based MammaPrint® BluePrint® Breast Cancer Kit to Market

RIJSWIJK, NETHERLANDS and IRVINE, CA, AMSTERDAM, – 19 December 2017 – BlueBee, a company driving global genomic data-driven medicine, and Agendia, Inc, a world leader in personalized medicine and molecular cancer diagnostics, have partnered to provide a secure, convenient, data processing solution for Agendia’s MammaPrint BluePrint Breast Cancer Recurrence and...
Read more
December 7, 2017

BlueBee adds NEN 7510:2011 Certification to its Security Portfolio

Read more
November 16, 2017

SLAMdunk – Another Optimized Lexogen, BlueBee Pipeline to Simplify Data Analysis

In September this year, Lexogen released the family of SLAMseq Metabolic RNA labeling kits, the underlying methodology of which is based on S4U labeling of RNA in cell cultures, alkylation of RNA with iodoacetamide, and the consequent introduction of T to C mutations in cDNA. To simplify the data analysis component...
Read more
Request A Demo